Zimmer Biomet Holdings Inc stock is traded at $108.33, with a volume of 2,487,477. It is up +2.59% in the last 24 hours and up +21.53% over the past month. Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Previous Close:
$105.59
Open:
$106.43
24h Volume:
2,487,477
Relative Volume:
0.83
Market Cap:
$20.50B
Revenue:
$8.41B
Net Income/Loss:
$760.80M
P/E Ratio:
28.13
EPS:
$3.85
Net Cash Flow:
$1.05B
1W Performance:
+11.28%
1M Performance:
+21.53%
6M Performance:
+31.58%
1Y Performance:
+22.41%
1-Day Range:
$105.51$109.32
1-Week Range:
$101.35$112.55
52-Week Range:
$79.12$112.55
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings IncSector
HealthcareIndustry
Medical DevicesPhone
(574) 267-6131Address
345 EAST MAIN STREET, WARSAW, IN, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS